Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity

Molecular and Cellular Biology

Volumn 24, Issue 18, 2004, Pages 8264-8275

  Zhu, Bangmin ^b   Gulick, Tod ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; HYBRID PROTEIN; ISOPROTEIN; MESSENGER RNA PRECURSOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2C; MYOD PROTEIN; PHOSPHOSERINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GAL4; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL STRAIN COS1; DIMERIZATION; DOWN REGULATION; EXON; FIBROBLAST; GENE EXPRESSION; GENE REPRESSION; HEART; HELA CELL; HUMAN; HUMAN CELL; MUSCLE; MUSCLE CELL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REACTION ANALYSIS; RNA SPLICING; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TRANSACTIVATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; COS CELLS; DNA; HELA CELLS; HUMANS; MADS DOMAIN PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MOLECULAR SEQUENCE DATA; MUSCLE DEVELOPMENT; MYOGENIC REGULATORY FACTORS; PHOSPHORYLATION; PROTEIN ISOFORMS; RECOMBINANT FUSION PROTEINS; RNA PRECURSORS; SEQUENCE HOMOLOGY, AMINO ACID; SERINE; TRANS-ACTIVATION (GENETICS);

ANIMALIA; VERTEBRATA;

EID: 4444380996     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.18.8264-8275.2004     Document Type: Article

References (53)

1. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1998. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
2. Bader, D., T. Masaki, and D. A. Fischman. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95:763-770.
3. Bergstrom, D. A., B. H. Penn, A. Strand, R. L. Perry, M. A. Rudnicki, and S. J. Tapscott. 2002. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9:587-600.
4. Black, B. L., J. Lu, and E. N. Olson. 1997. The MEF2A 3′ untranslated region functions as a cis-acting translational repressor. Mol. Cell. Biol. 17:2756-2763.
5. Black, B. L., and E. N. Olson. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167-196.
6. Black, D. L. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:291-336.
7. Breitbart, R. E., C. S. Liang, L. B. Smoot, D. A. Laheru, V. Mahdavi, and B. Nadal-Ginard. 1993. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development 118:1095-1106.
8. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
9. De Angelis, L., S. Borghi, R. Melchionna, L. Berghella, M. Baccarani-Contri, F. Parise, S. Ferrari, and G. Cossu. 1998. Inhibition of myogenesis by transforming growth factor beta is density-dependent and related to the translocation of transcription factor MEF2 to the cytoplasm. Proc. Natl. Acad. Sci. USA 95:12358-12363.
10. Dhavan, R., and L.-H. Tsai. 2001. A decade of cdk5. Nat. Rev. Mol. Cell Biol. 2:7879-7891.
11. Dodou, E., D. B. Sparrow, T. Mohun, and R. Treisman. 1995. MEF2 proteins, including MEF2A, are expressed in both muscle and non-muscle cells. Nucleic Acids Res. 23:4267-4274.
12. Edmondson, D. G., G. E. Lyons, J. F. Martin, and E. N. Olson. 1994. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 120:1251-1263.
13. Gong, X., X. Tang, M. Wiedmann, X. Wang, J. Peng, D. Zheng, L. A. C. Blair, J. Marshall, and Z. Mao. 2003. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38:33-46.
14. Gunthorpe, D., K. E. Beatty, and M. V. Taylor. 1999. Different levels, but not different isoforms, of the Drosophila transcription factor DMEF2 affect distinct aspects of muscle differentiation. Dev. Biol. 215:130-145.
15. Han, J., Y. Jiang, Z. Li, V. V. Kravchenko, and R. J. Ulevitch. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296-299.
16. Han, T. H., and R. Prywes. 1995. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol. Cell. Biol. 15:2907-2915.
17. Janson, C. G., Y. Chen, Y. Li, and D. Leifer. 2001. Functional regulatory regions of human transcription factor MEF2C. Mol. Brain Res. 97:70-82.
18. Kato, Y., M. Zhao, A. Morikawa, T. Sugiyama, D. Chakravortty, N. Koide, T. Yoshida, R. I. Tapping, Y. Yang, T. Yokochi, and J. D. Lee. 2000. Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J. Biol. Chem. 275:18534-18540.
19. Lazaro, J. B., P. J. Bailey, and A. B. Lassar. 2002. Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation. Genes Dev. 16:1792-1805.
20. Lazaro, J. B., M. Kitzmann, M. A. Poul, M. Vandromme, N. J. C. Lamb, and A. Fernandez. 1997. Cyclin dependent kinase 5, cdk5, a positive regulator of myogenesis in mouse C2 cells. J. Cell Sci. 110:1251-1260.
21. Lee, Y., B. Nadal-Ginard, V. Mahdavi, and S. Izumo. 1997. Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene. Mol. Cell. Biol. 17:2745-2755.
22. Lin, J., H. Wu, P. T. Tarr, C. Y. Zhang, Z. Wu, O. Boss, L. F. Michael, P. Puigserver, E. Isotani, E. N. Olson, B. B. Lowell, R. Bassel-Duby, and B. M. Spiegelman. 2002. Transcriptional co-activator PGC-1alpha drives the formation of slow-twitch muscle fibres. Nature 418:797-801.
23. Lin, Q., J. Lu, H. Yanagisawa, R. Webb, G. E. Lyons, J. A. Richardson, and E. N. Olson. 1998. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125:4565-4574.
24. Lin, Q., J. Schwarz, C. Bucana, and E. N. Olson. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-1407.
25. Liu, S., P. Liu, A. Borras, T. Chatila, and S. H. Speck. 1997. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 16:143-153.
26. Mao, Z., A. Bonni, F. Xia, M. Nadal-Vicens, and M. E. Greenberg. 1999. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286:785-790.
27. Martin, J. F., J. M. Miano, C. M. Hustad, N. G. Copeland, N. A. Jenkins, and E. N. Olson. 1994. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 14:1647-1656.
28. Martin, J. F., J. J. Schwarz, and E. N. Olson. 1993. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc. Natl. Acad. Sci. USA 90:5282-5286.
29. McDermott, J. C., M. C. Cardoso, Y. T. Yu, V. Andres, D. Leifer, D. Krainc, S. A. Lipton, and B. Nadal-Ginard. 1993. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell. Biol. 13:2564-2577.
30. McKinsey, T. A., C. L. Zhang, J. Lu, and E. N. Olson. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106-111.
31. McKinsey, T. A., C. L. Zhang, and E. N. Olson. 2001. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11:497-504.
32. McKinsey, T. A., C. L. Zhang, and E. N. Olson. 2002. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 27:40-47.
33. Miska, E. A., C. Karlsson, E. Langley, S. J. Nielsen, J. Pines, and T. Kouzarides. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099-5107.
34. Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125-1136.
35. Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1996. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol. Cell. Biol. 16:2627-2636.
36. Mora, S., and J. E. Pessin. 2000. The MEF2A isoform is required for striated muscle-specific expression of the insulin-responsive GLUT4 glucose transporter. J. Biol. Chem. 275:16323-16328.
37. Naya, F. J., B. L. Black, H. Wu, R. Bassel-Duby, J. A. Richardson, J. A. Hill, and E. N. Olson. 2002. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 8:1303-1309.
38. Naya, F. S., and E. Olson. 1999. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol. 11:683-688.
39. Okamoto, S., D. Krainc, K. Sherman, and S. A. Lipton. 2000. Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc. Natl. Acad. Sci. USA 97:7561-7566.
40. Okamoto, S., Z. Li, C. Ju, M. N. Scholzke, E. Mathews, J. Cui, G. S. Salvesen, E. Bossy-Wetzel, and S. A. Lipton. 2002. Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 99:3974-3979.
41. Ornatsky, O. I., and J. C. McDermott. 1996. MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells. J. Biol. Chem. 271:24927-24933.
42. Pollock, R., and R. Treisman. 1991. Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev. 5:2327-2341.
43. Raingeaud, J., A. J. Whitmarsh, T. Barrett, B. Derijard, and R. J. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247-1255.
44. Ridgeway, A. G., S. Wilton, and I. S. Skerjanc. 2000. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in P19 cells. J. Biol. Chem. 275:41-46.
45. Sartorelli, V., J. Huang, Y. Hamamori, and L. Kedes. 1997. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17:1010-1026.
46. Suzuki, E., J. Lowry, G. Sonoda, J. R. Testa, and K. Walsh. 1996. Structures and chromosome locations of the human MEF2A gene and a pseudogene MEF2AP. Cytogenet. Cell Genet. 73:244-249.
47. Wang, D. Z., M. R. Valdez, J. McAnally, J. Richardson, and E. N. Olson. 2001. The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development 128:4623-4633.
48. Wu, H., F. J. Naya, T. A. McKinsey, B. Mercer, J. M. Shelton, E. R. Chin, A. R. Simard, R. N. Michel, R. Bassel-Duby, E. N. Olson, and R. S. Williams. 2000. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J. 19:1963-1973.
49. Yang, S. H., A. Galanis, and A. D. Sharrocks. 1999. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. Mol. Cell. Biol. 19:4028-4038.
50. Youn, H. D., T. A. Chatila, and J. O. Liu. 2000. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J. 19:4323-4331.
51. Yu, G. S., Y. C. Lu, and T. Gulick. 1998. Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase IB gene promoters by fatty acid enzyme substrate. J. Biol. Chem. 273:32901-32909.
52. Yu, Y. T., R. E. Breitbart, L. B. Smoot, Y. Lee, V. Mahdavi, and B. Nadal-Ginard. 1992. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 6:1783-1798.
53. Zhao, M., L. New, V. V. Kravchenko, Y. Kato, H. Gram, F. di Padova, E. N. Olson, R. J. Ulevitch, and J. Han. 1999. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19:21-30.